Evidence map›Paper›PMID 40961449›Full record

ArticleThe New England journal of medicine2025

Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.

Rebecca Smith-Bindman, Susan A Alber, Marilyn L Kwan, Priscila Pequeno, Wesley E Bolch, Erin J A Bowles, Robert T Greenlee, Natasha K Stout, Sheila Weinmann, Lisa M Moy and 8 more

Abstract readMulticenter Study
In one paragraph

Article in The New England journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Rebecca Smith-BindmanDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco.
Susan A AlberDepartment of Public Health Sciences, University of California, Davis, Davis.
Marilyn L KwanDivision of Research, Kaiser Permanente Northern California, Pleasanton.
Priscila PequenoInstitute for Clinical Evaluative Sciences, Toronto.
Wesley E BolchJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville.
Erin J A BowlesKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle.
Robert T GreenleeMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI.
Natasha K StoutDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston.
Sheila WeinmannKaiser Permanente Center for Health Research, Portland, OR.
Lisa M MoyDivision of Research, Kaiser Permanente Northern California, Pleasanton.
Carly StewartDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco.
Melanie FranciscoKaiser Permanente Center for Health Research, Portland, OR.
Cameron KoflerDepartment of Radiology, University of Chicago, Chicago.
James R DuncanInterventional Radiology Section, Washington University in St. Louis, St. Louis.
Jonathan DucoreDepartment of Pediatrics, University of California, Davis, Davis.
Malini MahendraPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco.
Jason D PoleInstitute for Clinical Evaluative Sciences, Toronto.
Diana L MigliorettiDepartment of Public Health Sciences, University of California, Davis, Davis.

Funding

Risk of Pediatric and Adolescent Cancer Associated with Medical ImagingR01CA185687 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KWAN, MARILYN L, MIGLIORETTI, DIANA L · 2015 to 2019
$10.0M
Group Health Cancer Research Program Research Specialist AwardR50CA211115 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BOWLES, ERIN JANELLE AIELLO · 2017 to 2021
$919k
SCIENTIFIC, OPERATIONS AND ADMINISTRATIVE RESOURCES (SOAR) TO THE NIH75N95021D00011 · NIDA · GAP SOLUTIONS, INC. · PI RUPPERT, STEVEN · 2025 to 2025
$775k
NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS R01 CA185687NCI NIH HHS R50 CA211115NHLBI NIH HHS 75N92021D00011NIDA NIH HHS 75N95021D00011NIH HHS NCI R01CA185687 and NCI R50CA211115
6 · The paper itself

Abstract

backgroundAssessing the risk of radiation-induced hematologic cancer from medical imaging in children and adolescents might support informed decisions on the use of imaging.

methodsWe followed a retrospective cohort of 3,724,623 children born between 1996 and 2016 in six U.S. health care systems and Ontario, Canada, until the earliest of cancer or benign-tumor diagnosis, death, end of health care coverage, an age of 21 years, or December 31, 2017. Radiation doses to active bone marrow from medical imaging were quantified. Associations between hematologic cancers and cumulative radiation exposure (vs. no exposure), with a lag of 6 months, were estimated with the use of continuous-time hazards models.

resultsDuring 35,715,325 person-years of follow-up (mean, 10.1 years per person), 2961 hematologic cancers were diagnosed, primarily lymphoid cancers (2349 [79.3%]), myeloid cancers or acute leukemia (460 [15.5%]), and histiocytic- or dendritic-cell cancers (129 [4.4%]). The mean (±SD) exposure among children exposed to at least 1 mGy was 14.0±23.1 mGy overall (for comparison, 13.7 mGy was the exposure from one computed tomographic [CT] scan of the head) and 24.5±36.4 mGy among children with hematologic cancer. Cancer risk increased with cumulative dose, with a relative risk (vs. no exposure) of 1.41 (95% confidence interval [CI], 1.11 to 1.78) for 1 to less than 5 mGy, 1.82 (95% CI, 1.33 to 2.43) for 15 to less than 20 mGy, and 3.59 (95% CI, 2.22 to 5.44) for 50 to less than 100 mGy. The cumulative radiation dose to bone marrow was associated with an increased risk of all hematologic cancers (excess relative risk per 100 mGy, 2.54 [95% CI, 1.70 to 3.51; P<0.001]; relative risk for 30 vs. 0 mGy, 1.76 [95% CI, 1.51 to 2.05]) and most tumor subtypes. The excess cumulative incidence of hematologic cancers by 21 years of age among children exposed to at least 30 mGy (mean, 57 mGy) was 25.6 per 10,000. We estimated that, in our cohort, 10.1% (95% CI, 5.8 to 14.2) of hematologic cancers may have been attributable to radiation exposure from medical imaging, with higher risks from the higher-dose medical-imaging tests such as CT.

conclusionsOur study suggests an association between exposure to radiation from medical imaging and a small but significantly increased risk of hematologic cancer among children and adolescents. (Funded by the National Cancer Institute and others.).

Indexed as

Diagnostic ImagingHematologic NeoplasmsNeoplasms, Radiation-InducedRadiation DosageRadiation ExposureAdolescentBone MarrowChildChild, PreschoolDose-Response Relationship, RadiationFemaleFollow-Up StudiesHumansInfantMaleOntario

Identifiers

PMID40961449
PMCPMC12445590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.